1. Home
  2. HFFG vs IPHA Comparison

HFFG vs IPHA Comparison

Compare HFFG & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$1.67

Market Cap

104.8M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.87

Market Cap

189.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HFFG
IPHA
Founded
1997
1999
Country
United States
France
Employees
960
163
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.8M
189.5M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
HFFG
IPHA
Price
$1.67
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$6.00
$5.75
AVG Volume (30 Days)
369.3K
9.5K
Earning Date
05-11-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
20.65
N/A
EPS
0.02
N/A
Revenue
$1,228,282,000.00
N/A
Revenue This Year
$5.59
$180.36
Revenue Next Year
$2.24
N/A
P/E Ratio
$79.50
N/A
Revenue Growth
2.21
N/A
52 Week Low
$1.38
$1.18
52 Week High
$3.86
$2.63

Technical Indicators

Market Signals
Indicator
HFFG
IPHA
Relative Strength Index (RSI) 40.97 51.91
Support Level $1.38 $1.73
Resistance Level $2.30 $1.97
Average True Range (ATR) 0.13 0.08
MACD -0.03 -0.01
Stochastic Oscillator 40.95 31.69

Price Performance

Historical Comparison
HFFG
IPHA

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, frozen and dry food, and non-food products to Asian restaurants and other foodservice customers throughout the United States. The company's business consists of one operating segment: HF Group, which operates solely in the United States. The company's product list consists of Meat, Poultry & Seafood, Sauces & Oils, Takeout Items (Boxes, Chopsticks & Utensils), Raw Ingredients (Flour, Cornstarch, Spices), Cleaning Supplies, and Rice & Grains.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: